Alnylam Pharmace. buy Chardan Capital
Start price
02.05.25
/
50%
€229.30
Target price
02.05.26
€287.76
Performance (%)
10.95%
End price
03.05.26
€254.40
Summary
This prediction ended on 03.05.26 with a price of €254.40. The BUY prediction by Chardan_Capital finished with a performance of 10.95%. Chardan_Capital has a follow-up prediction for Alnylam Pharmace. where he still thinks Alnylam Pharmace. is a Buy. Chardan_Capital has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
AI-generated
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Alnylam Pharmace. | 5.189% | 5.189% | -48.952% |
| iShares Core DAX® | 1.842% | 1.387% | 8.651% |
| iShares Nasdaq 100 | 4.659% | -1.797% | 27.823% |
| iShares Nikkei 225® | 3.963% | -5.216% | 51.810% |
| iShares S&P 500 | 3.700% | 1.576% | 24.086% |
Comments by Chardan_Capital for this prediction
In the thread Alnylam Pharmace. diskutieren
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its price target raised by analysts at Chardan Capital from $300.00 to $325.00. They now have a "buy" rating on the stock.
Ratings data for ALNY provided by MarketBeat
In the thread Trading Alnylam Pharmace.
Die von Chardan_Capital gewählte maximale Laufzeit wurde überschritten
Current prediction by Chardan_Capital for Alnylam Pharmace.
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€281.10
25.03.26
25.03.26
€366.18
25.03.27
25.03.27
-32.53%
20:39
20:39
Stopped prediction by Chardan_Capital for Alnylam Pharmace.
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€236.90
26.02.25
26.02.25
€286.08
26.02.26
26.02.26
18.66%
27.02.26
27.02.26
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€260.20
11.10.24
11.10.24
€274.17
11.10.25
11.10.25
52.23%
12.10.25
12.10.25
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€139.00
16.02.24
16.02.24
€209.30
16.02.25
16.02.25
77.27%
17.02.25
17.02.25
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€168.60
08.08.23
08.08.23
€228.30
08.08.24
08.08.24
46.56%
09.08.24
09.08.24